Workflow
PLDT(PHI) - 2025 Q1 - Earnings Call Transcript
2025-05-15 08:30
PLDT (PHI) Q1 2025 Earnings Call May 15, 2025 03:30 AM ET Speaker0 Good afternoon, everyone. Thank you for joining us today. I'm Jingay Nabrales, Head of Investor Relations here at PLDT. It's my pleasure to welcome you to our first quarter financial and operations results briefing. Joining us today to share insights into PLDT's performance and strategic direction are Smart Communications Chief Operating Officer, Voin Marquez PLDT Chief Operating Officer, Jimenez Junior PLDT Chief Financial Officer, Mr. Dann ...
Novavax (NVAX) 2025 Earnings Call Presentation
2025-05-15 07:51
Novavax Corporate Presentation May 2025 © 2025 NOVAVAX. All rights reserved. Cautionary Note Regarding Forward-Looking Statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. These forward-looking statements address various matters including Novavax's corporate strat ...
Clover Health Investments (CLOV) 2025 Earnings Call Presentation
2025-05-15 07:50
Investor Presentation May 2025 Legal LGTM (PJR) 5.13.25 via Slack Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding Adjusted EBITDA, Adjusted Net income from continuing operations, Adjusted SG&A, Adjusted SG&A as a percentage of revenue, Insurance BER (non-GAAP measures, as defined herein) ...
4D Molecular Therapeutics (FDMT) 2025 Earnings Call Presentation
2025-05-15 07:50
This Presentation shall not constitute an offer to sell or the solicitation of an offer to buy securities. © 2025 4D Molecular Therapeutics. All Rights Reserved. 2 Bank of America 2025 Healthcare Conference Corporate Presentation May 2025 © 2025 4D Molecular Therapeutics. All Rights Reserved. © 2025 4D Molecular Therapeutics. All Rights Reserved. Legal Disclaimer This Presentation contains forward looking statements that involve substantial risks and uncertainties. All statements, other than statements of h ...
Amphastar Pharmaceuticals (AMPH) 2025 Earnings Call Presentation
2025-05-15 07:48
All statements in this presentation and in the conference call referenced above that are not historical are forward-looking statements, including, among other things, statements relating to our expectations regarding future financial performance and business trends, our future growth, sales and marketing of our products, market size and expansion, product portfolio, product development, the timing of FDA filings or approvals, including the DMFs of ANP, the timing of product launches, acquisitions and other ...
Spire (SPIR) - 2025 Q1 - Earnings Call Presentation
2025-05-15 07:33
Spire Global Q1 2024 Investor Update May 15, 2024 DISCLAIMER AND FORWARD–LOOKING STATEMENTS This presentation contains forward-looking statements, including information about management's view of Spire's future expectations, plans and prospects, including our views regarding future execution within our business, and the opportunity we see in our industry, within the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertaint ...
TMC the metal company (TMC) - 2025 Q1 - Earnings Call Presentation
2025-05-15 07:28
Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, those set forth under the heading "Risk Factors" contained in TMC's Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on March 27, 2025, as well as any updates to those risk factors filed from time to time in TMC's subsequent periodic and current reports. All information in this present ...
Investcorp Credit Management BDC(ICMB) - 2025 Q3 - Earnings Call Presentation
2025-05-15 07:18
Investor Update Presentation March 31, 2025 LOS ANGELES NEW YORK LONDON BAHRAIN ABU DHABI RIYADH DOHA MUMBAI DELHI BEIJING SINGAPORE TOKYO Investcorp Credit Management BDC, Inc. Forward-looking Statements and Disclosures Statements included in this presentation may contain "forward-looking statements," which relate to future performance or financial condition of Investcorp Credit Management BDC, Inc. ("ICMB"). Forward-looking statements are based on estimates, projections, beliefs and assumptions of ICMB's ...
Arcos Dorados (ARCO) - 2025 Q1 - Earnings Call Presentation
2025-05-15 07:17
2 Agenda First Quarter 2025 Results Arcos Dorados May 14, 2025 Disclaimer This presentation contains forward-looking statements that represent our beliefs, projections and predictions about future events or our future performance. Forward-looking statements can be identified by terminology such as "may," "will," "would," "could," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other similar expressions or phrases ...
Radcom(RDCM) - 2025 Q1 - Earnings Call Presentation
2025-05-15 07:12
Q1 - 2 5 Earnings May 14, 20 2 5 Benny Eppstein CEO This conference call will contain forward-looking statements. Forward-looking statements in the conference call involve several risks and uncertainties, including, but not limited, to the Company's statements about its momentum, strategic direction and trajectory, future execution and delivery of value to customers, development of and enhancing strategic partnerships and expected benefits from collaborations, the success of new technologies to, among other ...